Search Results - "Gevorkian, G."

Refine Results
  1. 1

    Carnot cycle at finite power: attainability of maximal efficiency by Allahverdyan, Armen E, Hovhannisyan, Karen V, Melkikh, Alexey V, Gevorkian, Sasun G

    Published in Physical review letters (01-08-2013)
    “…We want to understand whether and to what extent the maximal (Carnot) efficiency for heat engines can be reached at a finite power. To this end we generalize…”
    Get full text
    Journal Article
  2. 2

    Electric stimulation of the vagus nerve reduced mouse neuroinflammation induced by lipopolysaccharide by Meneses, G, Bautista, M, Florentino, A, Díaz, G, Acero, G, Besedovsky, H, Meneses, D, Fleury, A, Del Rey, A, Gevorkian, G, Fragoso, G, Sciutto, E

    Published in Journal of inflammation (London, England) (29-10-2016)
    “…Neuroinflammation (NI) is a key feature in the pathogenesis and progression of infectious and non-infectious neuropathologies, and its amelioration usually…”
    Get full text
    Journal Article
  3. 3

    Intranasal delivery of dexamethasone efficiently controls LPS‐induced murine neuroinflammation by Meneses, G., Gevorkian, G., Florentino, A., Bautista, M. A., Espinosa, A., Acero, G., Díaz, G., Fleury, A., Pérez Osorio, I. N., del Rey, A., Fragoso, G., Sciutto, E., Besedovsky, H.

    Published in Clinical and experimental immunology (01-12-2017)
    “…Summary Neuroinflammation is the hallmark of several infectious and neurodegenerative diseases. Synthetic glucocorticoids (GCs) are the first‐line…”
    Get full text
    Journal Article
  4. 4

    Stabilization and anomalous hydration of collagen fibril under heating by Gevorkian, Sasun G, Allahverdyan, Armen E, Gevorgyan, David S, Simonian, Aleksandr L, Hu, Chin-Kun

    Published in PloS one (11-11-2013)
    “…Type I collagen is the most common protein among higher vertebrates. It forms the basis of fibrous connective tissues (tendon, chord, skin, bones) and ensures…”
    Get full text
    Journal Article
  5. 5

    Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets by Servín-Blanco, R., Zamora-Alvarado, R., Gevorkian, G., Manoutcharian, K.

    Published in Human vaccines & immunotherapeutics (02-10-2016)
    “…Despite the impressive impact of vaccines on public health, the success of vaccines targeting many important pathogens and cancers has to date been limited…”
    Get full text
    Journal Article
  6. 6

    Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer’s disease brains by Gonzalez-Castro, R., Acero Galindo, G., García Salcedo, Y., Uribe Campero, L., Vazquez Perez, V., Carrillo-Tripp, M., Gevorkian, G., Gomez Lim, M. A.

    Published in Inflammopharmacology (01-06-2018)
    “…The main amyloid-beta (Aβ) variants detected in the human brain are full-length Aβ1–40 and Aβ1–42 peptides; however, a significant proportion of AD brain Aβ…”
    Get full text
    Journal Article
  7. 7

    Immunodominant epitope and properties of pyroglutamate-modified Aβ-specific antibodies produced in rabbits by Acero, G, Manoutcharian, K, Vasilevko, V, Munguia, M.E, Govezensky, T, Coronas, G, Luz-Madrigal, A, Cribbs, D.H, Gevorkian, G

    Published in Journal of neuroimmunology (18-08-2009)
    “…Abstract N-truncated and N-modified forms of amyloid beta (Aβ) peptide are found in diffused and dense core plaques in Alzheimer's disease (AD) and Down's…”
    Get full text
    Journal Article
  8. 8

    Novel amyloid-beta specific scFv and VH antibody fragments from human and mouse phage display antibody libraries by Medecigo, M, Manoutcharian, K, Vasilevko, V, Govezensky, T, Munguia, M.E, Becerril, B, Luz-Madrigal, A, Vaca, L, Cribbs, D.H, Gevorkian, G

    Published in Journal of neuroimmunology (01-06-2010)
    “…Abstract Anti-amyloid immunotherapy has been proposed as an appropriate therapeutic approach for Alzheimer's disease (AD). Significant efforts have been made…”
    Get full text
    Journal Article
  9. 9

    Thermal (in)stability of type I collagen fibrils by Gevorkian, S G, Allahverdyan, A E, Gevorgyan, D S, Simonian, A L

    Published in Physical review letters (30-01-2009)
    “…We measured the Young's modulus at temperatures ranging from 20 to 100 degrees C for a collagen fibril that is taken from a rat's tendon. The hydration change…”
    Get full text
    Journal Article
  10. 10

    Glassy state of native collagen fibril? by Gevorkian, S. G, Allahverdyan, A. E, Gevorgyan, D. S, Hu, C.-K

    Published in Europhysics letters (01-07-2011)
    “…Our micromechanical experiments show that viscoelastic features of type-I collagen fibril at physiological temperatures display essential dependence on the…”
    Get full text
    Journal Article
  11. 11

    Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico by Huerta, M, de Aluja, A.S, Fragoso, G, Toledo, A, Villalobos, N, Hernández, M, Gevorkian, G, Acero, G, Dı́az, A, Alvarez, I, Avila, R, Beltrán, C, Garcia, G, Martinez, J.J, Larralde, C, Sciutto, E

    Published in Vaccine (12-10-2001)
    “…Taenia solium cysticercosis seriously affects human health when localised in the central nervous system (CNS) and causes great economic loss in pig husbandry…”
    Get full text
    Journal Article
  12. 12

    Kinetics of the helix-coil transition by Allahverdyan, A. E, Gevorkian, S. G, Simonian, A

    Published in Europhysics letters (01-06-2009)
    “…Based on the Zimm-Bragg model we study cooperative helix-coil transition driven by a finite-speed change of temperature. There is an asymmetry between the coil…”
    Get full text
    Journal Article
  13. 13

    Epitope mapping and neuroprotective properties of a human single chain FV antibody that binds an internal epitope of amyloid-beta 1-42 by Solórzano-Vargas, R.S., Vasilevko, V., Acero, G., Ugen, K.E., Martinez, R., Govezensky, T., Vazquez-Ramirez, R., Kubli-Garfias, C., Cribbs, D.H., Manoutcharian, K., Gevorkian, G.

    Published in Molecular immunology (01-02-2008)
    “…Active and passive immunotherapy targeted at the amyloid-beta (Aβ) peptide has been proposed as therapeutic approach against Alzheimer's disease (AD), and…”
    Get full text
    Journal Article
  14. 14

    Human single chain Fv antibodies and a complementarity determining region-derived peptide binding to amyloid-beta 1–42 by Manoutcharian, K., Acero, G., Munguia, M.E., Becerril, B., Massieu, L., Govezensky, T., Ortiz, E., Marks, J.D., Cao, C., Ugen, K., Gevorkian, G.

    Published in Neurobiology of disease (01-10-2004)
    “…A library of phage-displayed human single-chain Fv (scFv) antibodies was selected against the human amyloid-beta peptide (Aβ42). Two new anti-Aβ42…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Phage displayed biomolecules as preventive and therapeutic agents by Manoutcharian, K, Gevorkian, G, Cano, A, Almagro, J C

    Published in Current pharmaceutical biotechnology (01-09-2001)
    “…Phage display is a powerful technology for selecting and engineering peptides and proteins expressed on the surface of filamentous bacteriophage. The…”
    Get more information
    Journal Article
  19. 19
  20. 20